A representative from Sanofi told Reuters that the safety of Beyfortus has been repeatedly shown in over 50 studies.
An internal memo written by the Food and Drug Administration’s top vaccine regulator offers a concerning glimpse into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback